Could tougher regulations in Europe now lead to a change of heart in France?
This article was originally published in Clinica
One of the originators of the French healthcare product safety bill has told Clinica that he may be persuaded to propose dropping the provision which would require a three-month notification procedure for medical devices during the second reading of the bill in the Senate. But he will only do so if he is convinced that there are now sufficient guarantees to ensure the safety of high-risk devices.
You may also be interested in...
The company is looking at deals in the $2bn to $5bn range, CEO Paul Hudson told investors, but premiums for assets are high and Sanofi is looking at earlier-stage opportunities as a result.
The physician who led the first first-in-human robotic-assisted neurovascular intervention with Corindus’ CorPath GRX system believes the technology could revolutionize neurovascular intervention by allowing a centralized interventional team to remotely treat patients.